Manténgase sano!

Resultados de su búsqueda "Weight Loss".

11 Nov

Popular Diabetes and Weight-Loss Drugs May Protect Stroke Survivors from Future Attacks, Study Finds

New research shows GLP-1 agonists, like Ozempic, and SGLT2 inhibitors, like Farxiga, help lower the risk of secondary stroke, heart attack and death in stroke survivors.

04 Sep

Taking Ozempic or Wegovy Does Not Increase Risk for Mental Health Issues, Study Finds

Researchers find no link between semaglutide, the main ingredient in Ozempic and Wegovy, and depression, suicidal thoughts or behaviors in patients with no prior history of the conditions.

Resultados de noticias de salud - 176

11 Nov
Weight Loss Meds Help Stroke Survivors Prevent Stroke Recurrence, Death

Weight Loss Meds Help Stroke Survivors Prevent Stroke Recurrence, Death

The weight-loss drug Ozempic can help reduce stroke patients’ risk of a heart attack or death, a new study says.

GLP-1 weight-loss...

09 Nov
Unexplained Weight Loss and What It Can Mean for Your Health

Unexplained Weight Loss and What It Can Mean for Your Health

It may seem counter-intuitive, but losing weight without even trying may not be a good thing.

"It's not typical to have a noticeable drop in weight without changing how much you're eating, being more physically active or trying to lose weight," said dietitian

05 Nov
Medicaid Covers GLP-1 Meds for Obesity in Just 13 States

Medicaid Covers GLP-1 Meds for Obesity in Just 13 States

Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discov...

01 Nov
Ozempic, Wegovy Could Help Ease Knee Arthritis Pain

Ozempic, Wegovy Could Help Ease Knee Arthritis Pain

The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found.

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss medication Wegovy -- had a nearly 14% dec...

28 Oct
Ozempic Curbs Kidney Disease in Obese People Without Diabetes

Ozempic Curbs Kidney Disease in Obese People Without Diabetes

The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows.

Patients taking semaglutide -- the active agent in Ozempic and Wegovy -- had as ...

25 Oct
Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds

Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.

Prescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled between 2022 and...

24 Oct
Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes

Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes

Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says.

People with type 2 diabetes taking semaglutide appeared to have a significantly...

24 Oct
Greater Access to New Weight Loss Meds Could Save More Than 40,000 Lives Per Year

Greater Access to New Weight Loss Meds Could Save More Than 40,000 Lives Per Year

Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and Zepbound could prevent more than 42,000 deaths a year...

15 Oct
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now

FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage list.

What prompted the FDA to reconsider its

14 Oct
GLP-1 Weight-Loss Meds Won't Raise Teens' Suicide Risk, May Even Lower It

GLP-1 Weight-Loss Meds Won't Raise Teens' Suicide Risk, May Even Lower It

As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts.

But a new study involving more than 54,000 U.S. adolescents found no such...

14 Oct
Ozempic Plus Intestinal 'Zap' Therapy May Eliminate Need for Insulin in Type 2 Diabetics

Ozempic Plus Intestinal 'Zap' Therapy May Eliminate Need for Insulin in Type 2 Diabetics

Results from a very small study suggest that a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could help erase the need for insulin in folks with type 2 diabetes.

The new trial hasn't yet been published in a peer-reviewed journal and...

11 Oct
Could Certain Genes Help You Slim Down?

Could Certain Genes Help You Slim Down?

The key to weight loss could come down to a combination of 14 “skinny genes,” a recent study says.

People with these genes dropped twice as much weight through regular exercise compared to those without the genes, researchers found.

Those with the most ...

09 Oct
Only 1 in 5 Large Companies' Health Plans Cover New Weight-Loss Meds for Employees

Only 1 in 5 Large Companies' Health Plans Cover New Weight-Loss Meds for Employees

When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies cover the medications in their health insurance plans, a new survey shows.

In a report published Wednesday in the journal

01 Oct
GLP-1 Weight-Loss Meds Could Interfere With Endoscopy, Colonoscopy

GLP-1 Weight-Loss Meds Could Interfere With Endoscopy, Colonoscopy

Food left in the stomach or stool left in the bowel can impede a doctor's ability to successfully perform an endoscopy or colonoscopy.

Now, research finds this scenario is more lik...

25 Sep
Could Ozempic Help Prevent Opioid Overdoses?

Could Ozempic Help Prevent Opioid Overdoses?

In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications might also lower people’s risk of opioid overdose.

...

25 Sep
Novo Nordisk CEO Grilled by Congress Over Price of Ozempic

Novo Nordisk CEO Grilled by Congress Over Price of Ozempic

During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company's high prices for its block...

20 Sep
Endurance Exercise Can Get Rid of Body Fat, Even Without Weight Loss

Endurance Exercise Can Get Rid of Body Fat, Even Without Weight Loss

Heavy-duty endurance exercise can cause body fat levels to drop without any accompanying weight loss, a new small-scale study indicates.

A group of eleven middle-aged men who cycled 710 miles in seven days lost only about 1% of their total weight, because they ate and dr...

18 Sep
Cost Has Many Going Around Doctors to Get Weight-Loss Meds

Cost Has Many Going Around Doctors to Get Weight-Loss Meds

Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days.

They’re in short supply, and often too expensive to afford without insurance cover...

16 Sep
Ozempic Could Curb Progression of Diabetes-Linked Liver Disease

Ozempic Could Curb Progression of Diabetes-Linked Liver Disease

Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that.

In a new decades-long study, veterans with diabetes...

13 Sep
Ozempic or Saxenda for Weight Loss: Which Works Best?

Ozempic or Saxenda for Weight Loss: Which Works Best?

Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same hormone associated with blood sugar and appetite, a new study finds.<...

13 Sep
Ozempic, Mounjaro Help People With Type 1 Diabetes Control Blood Sugar, Lose Weight

Ozempic, Mounjaro Help People With Type 1 Diabetes Control Blood Sugar, Lose Weight

Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and control their blood sugar levels, a n...

12 Sep
In Every U.S. State, at Least 1 in 5 People Is Now Obese

In Every U.S. State, at Least 1 in 5 People Is Now Obese

Statistics from 2023 on U.S. obesity rates bring no good news: In every state in the nation, 1 in every 5 people is now obese, the new tally shows.

In 2013, not one state had an adult obesity rate topping 35%, but 10 years later 23 states had achieved that dubious distin...

12 Sep
Weight-Loss Drug Zepbound May Work Better in Women Than Men

Weight-Loss Drug Zepbound May Work Better in Women Than Men

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval.

All doses of tirzepatide consistently reduced weight in...

12 Sep
Ozempic Can Prevent Heart Trouble in Folks With Kidney Issues

Ozempic Can Prevent Heart Trouble in Folks With Kidney Issues

Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows.

The drugs’ a...

11 Sep
Weight-Loss Pill Saxenda Helps Kids as Young as 6

Weight-Loss Pill Saxenda Helps Kids as Young as 6

The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report.

The findings, published Tuesday in the New England Journal of Medicine and...

11 Sep
Daily Pill Helps People Lose Weight, Combines GLP-1 With Other Drug

Daily Pill Helps People Lose Weight, Combines GLP-1 With Other Drug

An experimental weight-loss pill appears to help people quickly shed pounds, a new study says.

People who took the drug amycretin lost up to 13% of their body weight over three months, according to early clinical trial results presented at the European Association for th...

09 Sep
Obesity Raises Risk of Severe Infection, Especially in People With Diabetes

Obesity Raises Risk of Severe Infection, Especially in People With Diabetes

Losing weight can help a person with obesity -- especially those with diabetes -- fend off serious infections, new data shows.

It's an important finding, since "up to one in three hospitalizations in people with diabetes are for infections and people with diabetes are tw...

09 Sep
Wegovy, Ozempic May Someday Be Given as Once-Monthly Injection

Wegovy, Ozempic May Someday Be Given as Once-Monthly Injection

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study demonstrates.

...

03 Sep
Ozempic, Wegovy Won't Raise User's Suicide Risk, Study Finds

Ozempic, Wegovy Won't Raise User's Suicide Risk, Study Finds

The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects from taking Ozempic or

03 Sep
Taking Wegovy, Zepbound? One Expert Has Dietary Advice

Taking Wegovy, Zepbound? One Expert Has Dietary Advice

Folks taking weight-loss drugs like Wegovy or Zepbound might think they’ve found a shortcut to better health.

But they sti...

30 Aug
Ozempic, Wegovy Have Health Benefits Beyond Weight Loss, Studies Find

Ozempic, Wegovy Have Health Benefits Beyond Weight Loss, Studies Find

New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways.

These two injected drugs are versions of semaglutide. In multiple new data analyses, the d...

29 Aug
Why Breast Feeding May Be Even Healthier for Heavier New Moms

Why Breast Feeding May Be Even Healthier for Heavier New Moms

Breastfeeding helps women shed those extra pounds of "pregnancy weight," a new study finds, and the effect is even more pronounced for moms who were overweight before their pregnancy.

Among women who exclusively breastfed their baby during its first year, women who were...

27 Aug
3.6 Million Americans Could Be Covered for Wegovy Under New Medicare Rules

3.6 Million Americans Could Be Covered for Wegovy Under New Medicare Rules

New Medicare rules could make 3.6 million Americans -- or even more -- eligible for treatment with the pricey weight-loss drug Wegovy, a new study finds.

Under the new rules, the...

12 Aug
Getting Fats From Plants Vs. Animals Boosts Your Life Span

Getting Fats From Plants Vs. Animals Boosts Your Life Span

A study of more than 400,000 people tracked for up to 24 years finds that those who got their dietary fat from plants versus animals had significantly lower odds of dying during the study period.

Plant-based fats' benefit included a reduced odds for deaths due to heart d...

07 Aug
Cost Keeps Many Who Need Them  From Getting New Weight-Loss Meds

Cost Keeps Many Who Need Them From Getting New Weight-Loss Meds

WEDNESDAY, Aug. 7, 2024 (HealthDay news) -- Medicare and Medicaid patients are less likely to get cutting-edge weight-loss drugs than people with private insurance are, a new study finds.

Medicaid accounted for less than 10% of semaglutide (

02 Aug
Legit Ozempic Sales Soar While Counterfeits Put Patients in Danger

Legit Ozempic Sales Soar While Counterfeits Put Patients in Danger

Two new studies show how eager Americans are to obtain either safe, legitimate versions of Ozempic or counterfeit and potentially dangerous forms of the diabetes/weight-loss drug.

One study ...

23 Jul
Study Finds Big Shift in Who's Using GLP-1 Meds Like Ozempic

Study Finds Big Shift in Who's Using GLP-1 Meds Like Ozempic

The boom in using GLP-1 drugs like Ozempic to treat obesity has resulted in a bust regarding the drugs’ original purpose, which was to treat type 2 diabetes, a new study finds.&...

12 Jul
Four in 10 Cancer Cases, Nearly Half of Cancer Deaths Linked to Lifestyle

Four in 10 Cancer Cases, Nearly Half of Cancer Deaths Linked to Lifestyle

Nearly half of cancer deaths and 4 of 10 cases of cancer are linked to a person's lifestyle, a new study says.

Cigarette smoking remains the biggest cancer risk, contributing to 30% of cancer deaths and 20% of cancer cases, results show.

But excess body weight, dri...

11 Jul
Only 1 in 4 Still Taking Ozempic, Wegovy for Weight Loss Two Years Later

Only 1 in 4 Still Taking Ozempic, Wegovy for Weight Loss Two Years Later

Three of four patients stop taking Ozempic or Wegovy two years after being prescribed the blockbuster drugs for weight loss, a new analysis shows.

Conducted by Prime Therapeutics and Magellan Rx Management (MRx), the

08 Jul
Mounjaro Bests Ozempic for Weight Loss

Mounjaro Bests Ozempic for Weight Loss

Mounjaro outperforms Ozempic in helping people lose weight, a new study shows.

People taking tirzepatide (Mounjaro, Zepbound)...

08 Jul
Wegovy, Ozempic Lower Risk of Many Obesity-Related Cancers

Wegovy, Ozempic Lower Risk of Many Obesity-Related Cancers

In yet another finding that touts the health benefits of wildly popular weight-loss medications like Wegovy and Ozempic, scientists report that taking the drugs may help reduce the risk of some cancers.

In a study published July 5 in

02 Jul
Another Study Suggests GLP-1 Meds Could Ease Alcoholism

Another Study Suggests GLP-1 Meds Could Ease Alcoholism

Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says.

People taking semaglutide had 50% to 56% decreased odds for either becoming alcoholic or relapsing into alcoholism, researchers reported recently in the journal

25 Jun
Wegovy Helps Heart Failure Patients Lose Weight, Improve Symptoms

Wegovy Helps Heart Failure Patients Lose Weight, Improve Symptoms

Weight-loss drugs like Wegovy can improve symptoms in heart failure patients, a new clinical trial shows.

Both men and women showed improved heart function after a year on

25 Jun
Healthy Weight Loss Could Lower Your Odds for Cancer

Healthy Weight Loss Could Lower Your Odds for Cancer

Losing weight can protect you against cancers related to obesity, a new study finds.

Obesity has been linked to higher risk of at least 13 types of cancer, researchers said. This is largely due to excess levels of hormones like estrogen and insulin.

But study resul...

21 Jun
GLP-1 Medicine Mounjaro May Be First Drug to Ease Sleep Apnea

GLP-1 Medicine Mounjaro May Be First Drug to Ease Sleep Apnea

A medication used to manage type 2 diabetes has been found effective in treating sleep apnea.

The worldwide clinical trial demonstrates that tirzepatide significantly lowers breathing interruptions during sleep, a key ...

21 Jun
WHO, Lilly Issue Warnings About Fake Weight-Loss Drugs

WHO, Lilly Issue Warnings About Fake Weight-Loss Drugs

Both the World Health Organization and Eli Lilly Co. warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous countries.

The WHO

20 Jun
Looking for Weight Loss? Go Nuts

Looking for Weight Loss? Go Nuts

Folks dieting to drop pounds should consider eating a fistful of nuts here and there, a new review suggests.

People who ate 1.5 to 3 ounces of almonds, peanuts, pistachios or walnuts daily as part of a calorie-cutting

11 Jun
Taking a GLP-1 Medicine? Here's What Experts Say You Should Eat

Taking a GLP-1 Medicine? Here's What Experts Say You Should Eat

Folks using a weight-loss drugs like Ozempic, Wegovy or Zepbound still have nutritional req...

04 Jun
Wegovy, Ozempic May Help Curb Alcohol Dependence

Wegovy, Ozempic May Help Curb Alcohol Dependence

Could the blockbuster GLP-1 meds like Wegovy and Ozempic have a role to play in helping people cut down on problem drinking? A new study suggests so.

Researchers at Case Western...

03 Jun
Could New Weight-Loss Drugs Be Changing Women's Taste for Sweets?

Could New Weight-Loss Drugs Be Changing Women's Taste for Sweets?

Ozempic and Wegovy appear to improve people's sensitivity to tastes, potentially lowering their desire for sweets, a new study suggests.

The active ingredient in the weight-loss ...

Mostrar todos los resultados de noticias de salud